According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$40.38 M. In 2023 the company made an earning of -A$39.56 M an increase over its 2022 earnings that were of -A$56.15 M.The earnings displayed on this page is the company's Pretax Income.